Lily Li

Lily Li

Auto-generated profile, based on publicly available information

Lily Li

Medicinal Inorganic Chemistry Group, Department of Chemistry University of British Columbia Vancouver British Columbia Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2020 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
LLLily Li
Lily Li
JRJulie Rousseau
Julie Rousseau
MJMaría de Guadalupe Jaraquemada-Peláez
María de Guadalupe Jaraquemada-Peláez
XWXiaozhu Wang
Xiaozhu Wang
ARAndrew Robertson
Andrew Robertson
COChris Orvig
Chris Orvig

22 April 2019 in Bioconjugate Chemistry
Verified
Journal Article
Open access
LLLily Li
Lily Li
MJMaría de Guadalupe Jaraquemada-Peláez
María de Guadalupe Jaraquemada-Peláez
HKHsiou-Ting Kuo
Hsiou-Ting Kuo
HMHelen Merkens
Helen Merkens
NCNeha Choudhary
Neha Choudhary
COChris Orvig
Chris Orvig
Here, we present the synthesis and characterization of a new potentially nonadentate chelator, H4pypa and its bifunctional analog tBu4pypa-C7-NHS conjugated to PSMA (prostate-specific membrane antigen) - targeting peptidomimetic (Glu-urea-Lys). H4pypa is very functionally versatile and biologically stable. Compared to the conventional chelators (e.g. DOTA, DTPA), H4pypa has outstanding affinities for both 111In (EC, t1/2 ~2.8 d) and 177Lu (-, t1/2~6.64 d). Its radiolabeled complexes were achieved at >98% radiochemical yield, RT within 10 minutes, at ligand concentration as low as 10-6 M, with excellent stability in human serum over at least 5-7 days (<1% transchelation). The thermodynamic stabilities of the [M(pypa)]- complexes (M3+ = In3+, Lu3+, La3+) were dependent on the ionic radii, where the smaller In3+ has the highest pM value (30.5), followed by Lu3+ (22.6) and La3+ (19.9). All pM values are remarkably higher than those with DOTA, DTPA, H4octapa, H4octox and H4neunpa. Moreover, the facile and versatile bifunctionalization enabled by the p-OH group in the central pyridyl bridge of the pypa scaffold (compound 14) allows incorporation of a variety of linkers for bioconjugation through easy nucleophilic substitution. In this work, an alkyl linker was selected to couple H4pypa to a PSMA-targeting pharmacophore, proving that the bioconjugation sacrifices neither the tumor-targeting nor the chelation properties. The biodistribution profiles of 111In- and 177Lu-labeled tracers are different, but promising, with the 177Lu analog particularly outstanding.

24 January 2020 in Inorganic Chemistry
Verified
Journal Article
Closed access
LLLily Li
Lily Li
MJMaría de Guadalupe Jaraquemada-Peláez
María de Guadalupe Jaraquemada-Peláez
EAEduardo Aluicio-Sarduy
Eduardo Aluicio-Sarduy
XWXiaozhu Wang
Xiaozhu Wang
DJDawei Jiang
Dawei Jiang
COChris Orvig
Chris Orvig

18 August 2020 in Journal of Labelled Compounds and Radiopharmaceuticals
Verified
Journal Article
Closed access
PDF file
MFMaryline G. Ferrier
Maryline G. Ferrier
YLYawen Li
Yawen Li
MCMing‐Kuan Chyan
Ming‐Kuan Chyan
RWRoger Wong
Roger Wong
LLLily Li
Lily Li
DWD. Scott Wilbur
D. Scott Wilbur

3 April 2020 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
LLLily Li
Lily Li
MJMaría de Guadalupe Jaraquemada-Peláez
María de Guadalupe Jaraquemada-Peláez
EAEduardo Aluicio-Sarduy
Eduardo Aluicio-Sarduy
XWXiaozhu Wang
Xiaozhu Wang
TBTodd E. Barnhart
Todd E. Barnhart
COChris Orvig
Chris Orvig
H4pypa was conjugated to an antibody via a newly synthesized H4pypa-phenyl-NCS; promising immuno-PET imaging with 44Sc was demonstrated.